27. The Future: A New Era in Cardiovascular Prevention

The introduction of lepodisiran and similar gene-targeted drugs signals a new era in cardiovascular prevention. By addressing genetic risk factors at their source, these therapies have the potential to prevent countless heart attacks and strokes, reshaping the landscape of heart disease treatment worldwide.
For more on what the future holds, explore Nature Reviews Cardiology.